Navin Pinto, MD

Graduate (2011)

Post Fellowship: Instructor, Pediatric Hematology/Oncology, University of Chicago



Type Institution Degree/Year Field of Study
College St. Louis Univ. BA/2001 Biology
Medical School St. Louis Univ. MD/2005  
Residency Univ. of Chicago 2008 Pediatrics
Fellowship Univ. of Chicago 2011 Peds Hem/Onc


Personal Statement

My decision to train in pediatric oncology at the University of Chicago was based on opportunities to have the best of both worlds: a small fellowship program with lots of one-on-one training from dedicated faculty members and world-class research similar to many of the large (6+ fellows/year) training programs.  We have exposure to patients with all major (and many minor) malignant and nonmalignant conditions.

My long term goal is to become a translational physician scientist focused on pharmacogenomics of treatment failure in patients with solid tumors and to develop novel treatment algorithms using genetic predictors of treatment response.


Living in Chicago

Chicago, in my opinion, is one of the best cities in the world.  The diversity of arts, cultural events and food is unsurpassed.   I live about 15 miles north of the medical center along the lake in the Andersonville neighborhood and my commute into work is 30-40 minutes.

My hobbies:

  • Bike touring the city
  • Trying new restaurants
  • Watching live music
  • Watching my new daughter grow



Cancer Research Foundation Young Investigator Award – 2011-2013

Scholar-in-Training Award, American Association for Cancer Research – 2011

National Institutes of Health Loan Repayment Program – 2011-2013

St. Baldrick’s Foundation Fellowship – 2010-2011

Best Poster Presentation, Clinical Category, Advances in Neuroblastoma Research Meeting, Stockholm, Sweden – 2010

American Society of Clinical Oncology Young Investigator Award – 2010

Fellow Teaching Award, University of Chicago Dept. of Pediatrics – 2009

November Employee of the Month, University of Chicago Medical Center – 2008

Senior Resident of the Year, University of Chicago Dept. of Pediatrics – 2008

Intern of the Year, University of Chicago Dept. of Pediatrics – 2006

Rodney M. Coe Distinction in Community Service, Saint Louis University School of Medicine – 2005

Alpha Omega Alpha Medical Honors Society, Saint Louis University School of Medicine – 2005

Summa cum laude, Saint Louis University – 2001



Pinto N, Onel K. “Towards Personalized Medicine in Pediatric Cancer: Genome-wide Strategies to Investigate Cancer Risk and Response to Therapy.” In press, in Pediatric Neoplasia; Lippincott, Williams and Wilkins

Pinto N, Cohn SL, Dolan ME. “Using Germline Genomics to Individualize Pediatric Cancer Treatments.”  In press, Clinical Cancer Research.

Pinto N, Dolan ME.  “Clinically Relevent Genetic Variations in Drug Metabolizing Enzymes.” Current Drug Metabolism 5(2011); 487-97. PMID: 21453273

Henderson TO, Bhatia S, Pinto N, London WB, McGrady P, Crotty C, Sun C-L, Cohn SL. “Racial and Ethnic Disparities in Risk and Survival in Children with Neuroblastoma: A Children’s Oncology Group (COG) Study.”  Journal of Clinical Oncology  1(2011); 76-82. PMID: 21098321

Pinto N, Ludeman SM, Dolan ME. “Drug Focus: Pharmacogenetic Studies Related to Cyclophosphamide-based Therapy.” Pharmacogenomics  10(2009); 1897-903. PMID: 19958089



Pinto N, Gamazon ER, Konkashbaev A, Cox NJ, Dolan ME, Diskin SJ, London WB, Maris JM, Cohn SL.  “Genomic ancestry is associated with risk group and survival in children with neuroblastoma”  Poster Presentation at Children’s Oncology Group Fall Meeting and American Association for Cancer Reseach Science of Cancer Health Disparities, September, 2011.

Pinto N, Gamazon E, Wheeler H, Cox N, Dolan ME.  “Pharmacogenomics of Cyclophosphamide: A Human Cell-Based Model Identifies Novel Functional Variants Important in Cellular Resistance”  Poster Presentation at American Society of Clinical Pharmacology and Therapeutics Annual Meeting, Dallas, TX. March, 2011

Pinto N, Henderson TO, Bhatia S, London WB, McGrady P, Crotty C, Sun CL, Cohn SL.  “Survival Variability by Race and Ethnicity in Neuroblastoma: A Children’s Oncology Group (COG) Study.” Oral Presentation at Advances in Neuroblastoma Research Meeting, Stockholm, Sweeden. June 2010

Pu Y, Applebaum D, Volchenboum S, Abe H, Penney B, Hara T, Shiraishi J, Doi K, Pinto N. “Both 4-hour and 24-hour Delayed Iodine-123 MIBG Images are Necessary for Optimal Detection of Bony and Soft Tissue Tumors in Neuroblastoma.” Society of Nuclear Medicine Annual Meeting, Salt Lake City, UT. June 2010.

Pinto N, Abe H, Appelbaum D, Hara T, Pu Y, Shiraishi J, Doi K, Cohn SL, Volchenboum SL. “Development of an Automated Quantatative Method for Scoring Metaiodobenzylguanine (mIBG) Scans in Patients with Neuroblastoma.”  Poster Presentations at ASPHO Annual Meeting, Montreal, Quebec April 2010 and Advances in Neuroblastoma Research Meeting, Stockholm, Sweden. June 2010.

Pinto N, Onel KB, Wagner-Weiner L, Lakser O, Spencer C.  “Pulmonary Alveolar Proteinosis in an 8 year-old girl with Systemic Onset Juvenile Idiopathic Arthritis.”  Arthritis and Rheumatism 54 (2006) s505. Poster Presentation at American College of Rheumatology Meeting, Washington DC, November 2006.


Meet our fellows